Can triple-negative endometrial cancer be cured?

Can endometrial cancer be cured? Many patients feel hopeless when it comes to diseases with the word "cancer" in their name. In fact, not all such diseases are incurable. Take endometrial cancer for example. It is one of the most common malignant tumors of the female reproductive organs, accounting for 20-30% of malignant tumors of the female reproductive tract. In recent years, the incidence of endometrial cancer has shown a clear upward trend. So can endometrial cancer be cured? You may know after reading the following introduction.

The occurrence of endometrial cancer is directly related to the continuous effect of estrogen. Long-term anovulation is the main risk factor for endometrial cancer. Estrogen can cause excessive proliferation of the endometrium, even atypical proliferation, and then endometrial cancer. The chance of atypical proliferation becoming cancer is about 10-25%. The risk of endometrial cancer in infertile, overweight and menopausal women later than 52 years old is 5 times that of fertile, normal weight and menopausal women before 49 years old.

Endometrial cancer can occur at any age, but it is basically a tumor of elderly women. According to the American Cancer Registry, the peak age of the disease is 58 to 61 years old. Various types of uterine bleeding are the most prominent symptoms of this disease. About 50% to 70% of patients develop the disease after menopause, while those who are not menopausal will experience irregular bleeding or increased menstrual flow and prolonged menstruation. Therefore, irregular vaginal bleeding in middle-aged and elderly women may be a sign of endometrial cancer and should be highly vigilant. Young patients should not take it lightly either.

Obtaining the endometrium through curettage for pathological examination is the main method for diagnosing this disease. In recent years, the widespread use of hysteroscopy in clinical practice has greatly improved the early diagnosis rate of endometrial cancer.

In addition, vaginal B-ultrasound, lymphangiography, CT, MRI, serum tumor marker testing, etc. are also helpful in the diagnosis and treatment decision-making of this disease.

In addition, surgery is the primary means of treating endometrial cancer. The main purpose of surgery is to remove the tumor, conduct comprehensive surgical-pathological staging of the patient, select the treatment method and judge the prognosis. The scope of surgery varies according to the patient's age, general condition, location of tumor growth, range of involvement, pathological type and grade. Even for advanced or recurrent cases, surgery can be considered for suitable patients after taking appropriate adjuvant treatments such as radiotherapy, hormone therapy or pelvic interventional therapy. After surgery, appropriate adjuvant treatments are taken according to high-risk pathological factors.

Endometrial cancer is easy to detect early because of its slow growth, late metastasis and obvious symptoms. Its treatment effect is relatively good, and the overall prognosis is better than other reproductive malignancies. The 5-year survival rate is 60-70 percent, and the 5-year survival rate is as high as 90%. As long as you cooperate with the doctor's active treatment, early endometrial cancer can be cured.